ArticleScientific reports2014

Readministration of EGFR tyrosine kinase inhibitor in non-small cell lung cancer patients after initial failure, what affects its efficacy?

Ze-Rui Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.